Redmile Group, LLC 13D and 13G filings for RAPT Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 8:02 pm Purchase | 2024-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | Redmile Group, LLC | 1,741,556 9.900% | 1,269,450 (+268.89%) | Filing |
| 2024-02-14 4:26 pm Purchase | 2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | Redmile Group, LLC | 472,106 9.900% | 12,126 (+2.64%) | Filing |
| 2023-02-14 4:21 pm Purchase | 2022-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | Redmile Group, LLC | 459,980 9.900% | 60,059 (+15.02%) | Filing |
| 2022-06-03 5:16 pm Purchase | 2022-05-24 | 13G | RAPT Therapeutics, Inc. RAPT | Redmile Group, LLC | 399,920 9.900% | 399,920 (New Position) | Filing |